Stories
Prime Therapeutics hailed as a Yellow Ribbon company
Designation signifies Prime's commitment to honoring and supporting active-duty military, veterans and their families
November 10, 2021The Minnesota Department of Military Affairs’ Beyond the Yellow Ribbon program named Prime Therapeutics (Prime) a Yellow Ribbon company for its support of Servicemembers and military families.
Prime’s work with the Yellow Ribbon program to develop a tailored action plan – demonstrating outward support for military employees and their families – culminated in the certification.
This year, Prime launched the Veterans, Families and Allies Network (VetFAN) employee resource group (ERG), a workplace group for military-affiliated employees and their supporters. One of the many changes Prime’s Beyond the Yellow Ribbon steering committee helped implement is an improved military leave policy, which provides 10 days of pay (in a rolling 12-month period) during an approved military leave.
“The Yellow Ribbon certification means Prime will join other companies and communities striving to serve our military families in a variety of ways,” said Dave Sagisser, manager, information technology and VetFAN co-chair for Prime. “Prime will become a ‘boots on the ground company’ that makes a difference for these families.”
“Officially being recognized as a Yellow Ribbon company is extremely important to Prime, its employees and its clients. It speaks to the commitment Prime has made to support our military and our country,” adds Marcus Caruso, director, shared services and Beyond the Yellow Ribbon steering committee member for Prime. “It signifies that Prime recognizes its employees who are either current or former military members, along with their families, are critical to the success of the organization.”
In 2022, Minnesota Governor Tim Walz will present Prime with the Yellow Ribbon certification in an official proclamation ceremony.
Read more about Prime’s support of employees serving in the military.
Related news
Stories
April 30, 2024
RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Stories
April 24, 2024
New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care
Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances
Stories
April 5, 2024
LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast
In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.